↓ Skip to main content

Dove Medical Press

Article Metrics

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

Overview of attention for article published in Vascular Health and Risk Management, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 319)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
1 blog
twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
19 Mendeley
Title
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
Published in
Vascular Health and Risk Management, November 2013
DOI 10.2147/vhrm.s54362
Pubmed ID
Authors

Peter Bramlage, Jochen Seufert, Katrin Pegelow

Abstract

For patients with type 2 diabetes who are uncontrolled on a combination of two oral antidiabetic agents, addition of the long-acting basal insulin glargine is a well established treatment option. However, data on the efficacy and safety of a combination of metformin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and insulin glargine are limited in real-world settings. Therefore, the aim of this study was to analyze blood glucose control, rates of hypoglycemia and body weight in a large cohort of patients with type 2 diabetes treated with this combination therapy in real practice.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Denmark 1 5%
Unknown 17 89%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 4 21%
Other 3 16%
Student > Doctoral Student 3 16%
Student > Master 3 16%
Librarian 2 11%
Other 3 16%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 15 79%
Social Sciences 1 5%
Agricultural and Biological Sciences 1 5%
Engineering 1 5%
Unknown 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2015.
All research outputs
#537,229
of 4,733,468 outputs
Outputs from Vascular Health and Risk Management
#23
of 319 outputs
Outputs of similar age
#14,146
of 105,110 outputs
Outputs of similar age from Vascular Health and Risk Management
#2
of 19 outputs
Altmetric has tracked 4,733,468 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 319 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,110 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.